Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial

Tze-Fan Chao1, Chia-Jen Liu2, Kang-Ling Wang1

  • 1Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan.

Insights

The CHA2DS2-VASc score is superior to the ATRIA score for predicting ischemic stroke in atrial fibrillation patients. ATRIA misclassifies many patients as low-risk, while CHA2DS2-VASc accurately identifies truly low-risk individuals.

Area of Science:

  • Cardiology
  • Neurology
  • Public Health

Background:

  • Atrial fibrillation (AF) necessitates risk stratification for ischemic stroke.
  • The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) score is a proposed system for AF risk assessment.
  • The ability of the ATRIA score to identify low-risk AF patients for stroke remains uncertain.

Purpose of the Study:

  • To compare the predictive performance of the ATRIA score against the CHA2DS2-VASc score for ischemic stroke in AF patients.
  • To evaluate the accuracy of both scoring systems in identifying low-risk individuals.

Main Methods:

  • Utilized the National Health Insurance research database in Taiwan.
  • Included 186,570 AF patients not receiving antithrombotic therapy.
  • Assessed ischemic stroke as the primary clinical endpoint over a mean follow-up of 3.4 years.

Main Results:

  • CHA2DS2-VASc demonstrated superior predictive accuracy over ATRIA (c-index 0.698 vs. 0.627, p < 0.0001).
  • CHA2DS2-VASc significantly improved risk reclassification by 11.7% compared to ATRIA (p < 0.0001).
  • Among patients with ATRIA score 0-5, CHA2DS2-VASc identified a wide range of stroke risks, with significantly better discrimination (c-index 0.629 vs. 0.593, p < 0.0001).

Conclusions:

  • The ATRIA score inadequately identifies low-risk AF patients, with annual stroke rates up to 2.95% at 1 year.
  • AF patients with a CHA2DS2-VASc score of 0 represent a truly low-risk group, with an approximate 1% annual stroke rate.
  • CHA2DS2-VASc is a more reliable tool for stroke risk stratification in AF patients compared to ATRIA.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
948
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
490
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
802
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
604
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
578
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
2.0K